An Act To Promote Prescription Drug Price Transparency
Sec. 1. 22 MRSA §8712, sub-§5 is enacted to read:
Sec. 2. Further data collection by Maine Health Data Organization. The Maine Health Data Organization shall develop a plan to collect data from manufacturers related to the cost and pricing of prescription drugs in order to provide transparency in and accountability for prescription drug pricing. The organization shall consult with other state and national agencies and organizations to determine how to institute such data collection. The organization shall submit the plan, its findings and any recommendations for suggested legislation to the First Regular Session of the 129th Legislature no later than April 1, 2019. The joint standing committee of the Legislature having jurisdiction over judiciary matters may report out legislation related to prescription drug price transparency and the organization's findings and recommendations to the First or Second Regular Session of the 129th Legislature.
Sec. 3. Appropriations and allocations. The following appropriations and allocations are made.
HEALTH DATA ORGANIZATION, MAINE
Maine Health Data Organization 0848
Initiative: Provides a one-time allocation to the Maine Health Data Organization to collect and present certain data to the Legislature and to develop a plan for further data collection.
|OTHER SPECIAL REVENUE FUNDS||2017-18||2018-19|
|OTHER SPECIAL REVENUE FUNDS TOTAL||$0||$25,000|